Skip to content

DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer

Development And Evaluation of The Effectiveness of A Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07512726
Enrollment
24
Registered
2026-04-06
Start date
2025-08-08
Completion date
2026-01-30
Last updated
2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Colorectal (Colon or Rectal) Cancer

Keywords

Colorectal Neoplasms, Quality of Life, Internet-Based Intervention, Symptom Control, Colorectal Cancer, Supportive Care

Brief summary

This study was designed to develop and evaluate the effectiveness of a web-based supportive care program for individuals diagnosed with colorectal cancer undergoing cancer treatment. The program's effectiveness is evaluated based on the symptom burden and quality of life experienced by patients during cancer treatment. This randomized controlled trial was conducted with the participation of patients diagnosed with colorectal cancer receiving treatment at the Outpatient Chemotherapy Unit of Koç University Hospital. Participants were divided into two groups: an intervention group and a control group. Patients in the intervention group were provided with access to the web-based 'Sağlıkta Buluşalım (Meet in Health) Supportive Care Program' for 3 months in addition to routine care, while the control group received standard care. Data collection tools included a Descriptive Information Form, Edmonton Symptom Assessment System (ESAS), Functional Assessment of Cancer Therapy-Colorectal (FACT-C), Website Usability Scale, and a Telephone Follow-up Form. Statistical analyses, including Mann-Whitney U, Pearson Chi-Square, Fisher's Exact, and Friedman tests, were planned to compare symptom levels and quality of life scores within and between groups over time.

Interventions

OTHERweb based supportive care programme

This study developed a supportive care program for individuals diagnosed with colorectal cancer who are undergoing cancer treatment, focusing on the symptoms and quality of life experienced by patients during treatment. The sub-headings and content of the planned program were prepared within the framework of the "Supportive Care Framework," frequently used for cancer patients. This framework, comprising 7 main concepts (physical, emotional, social, psychosocial, spiritual/mental, informational, and practical-daily life changes), aims to provide a holistic approach to patients' needs. Furthermore, the program content includes the experiences of individuals who have gone through similar experiences and have recovered from cancer. All these approaches constitute the unique values of this study.

Sponsors

Ilknur Yazicioglu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

The web-based supportive care program developed for this study was developed within the framework of supportive care. Developed by Margaret Fitch in 1994, the Supportive Care Framework is a holistic model designed to plan and organize service delivery for individuals living with cancer and their families (Fitch, 1994). This framework aims to guide cancer care professionals and managers in conceptualizing how to provide the assistance and services patients may need. The framework emphasizes that cancer care is not limited to medical treatment but also encompasses support needs in all areas affecting quality of life. • Fitch, M.I. (1994). Providing supportive care for individuals living with cancer (Task Force Report). Toronto: Ontario Cancer Treatment and Research Foundation

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of colon cancer and receiving cancer treatment (within the first 3 months of diagnosis) * Being 18 years of age or older * Being able to read, understand, and communicate in Turkish * Having internet access * Being able to use a smartphone or computer * Having access to a smartphone or computer * Voluntary participation in the study

Exclusion criteria

* Having a psychiatric illness * Having a disability that impairs cognitive functions * Refusing to participate in the study * Poor general health * Incompatibility between treatment appointments and the study's data collection schedule

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life Measured by the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) ScaleFrom enrollment to the end of treatment at 3 monthsThe Functional Assessment in Cancer Treatment-Colorectal Cancer Scale (FACT-C) was administered to evaluate the quality of life of patients undergoing chemotherapy. The scale is part of the Functional Assessment in Chronic Disease Treatment (FACIT) measurement system and is used to assess common conditions seen in all cancer patients, as well as specific concerns associated with colorectal cancer.
Symptom Severity Measured by the Edmonton Symptom Assessment ScaleFrom enrollment to the end of treatment at 3 monthsThe Edmonton Symptom Assessment Scale was used to evaluate the symptoms experienced by patients during chemotherapy treatment. The scale assesses 10 symptoms: pain, fatigue, nausea, sadness, anxiety, insomnia, loss of appetite, general malaise, shortness of breath, and other problems.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026